BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31867293)

  • 1. Antifungal Activity, Toxicity, and Membranolytic Action of a Mastoparan Analog Peptide.
    Singulani JL; Galeane MC; Ramos MD; Gomes PC; Dos Santos CT; de Souza BM; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
    Front Cell Infect Microbiol; 2019; 9():419. PubMed ID: 31867293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Antimicrobial Peptide MK58911-NH
    Singulani JL; Oliveira LT; Ramos MD; Fregonezi NF; Gomes PC; Galeane MC; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0090421. PubMed ID: 34516241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis.
    de Castro Spadari C; da Silva de Bastiani FWM; Pisani PBB; de Azevedo Melo AS; Ishida K
    Arch Microbiol; 2020 May; 202(4):773-784. PubMed ID: 31832690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
    Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
    Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Peptide from Budding Yeast GAPDH Serves as a Promising Antifungal against Cryptococcus neoformans.
    Zhang Y; Zhou L; Liu Y; Zhao X; Lian X; Zhang J; Zhao D; Wang Y; Zhong J; Wang J; Wang H; Wang L; Fu YV
    Microbiol Spectr; 2022 Feb; 10(1):e0082621. PubMed ID: 35019693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the antimicrobial activity of the mastoparan Polybia-MPII isolated from venom of the social wasp Pseudopolybia vespiceps testacea (Vespidae, Hymenoptera).
    Silva JC; Neto LM; Neves RC; Gonçalves JC; Trentini MM; Mucury-Filho R; Smidt KS; Fensterseifer IC; Silva ON; Lima LD; Clissa PB; Vilela N; Guilhelmelli F; Silva LP; Rangel M; Kipnis A; Silva-Pereira I; Franco OL; Junqueira-Kipnis AP; Bocca AL; Mortari MR
    Int J Antimicrob Agents; 2017 Feb; 49(2):167-175. PubMed ID: 28108242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the
    Tancer RJ; Wang Y; Pawar S; Xue C; Wiedman GR
    Microbiol Spectr; 2022 Apr; 10(2):e0043922. PubMed ID: 35377230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antimicrobial peptide DvAMP serves as a promising antifungal agent against Cryptococcus neoformans.
    Yang L; Tian Z; Zhao W; Zhang J; Tian C; Zhou L; Jiao Z; Peng J; Guo G
    Bioorg Chem; 2023 Sep; 138():106679. PubMed ID: 37329812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel alkylated azoles as potent antifungals.
    Shrestha SK; Garzan A; Garneau-Tsodikova S
    Eur J Med Chem; 2017 Jun; 133():309-318. PubMed ID: 28395217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal effect and action mechanism of antimicrobial peptide polybia-CP.
    Wang K; Jia F; Dang W; Zhao Y; Zhu R; Sun M; Qiu S; An X; Ma Z; Zhu Y; Yan J; Kong Z; Yan W; Wang R
    J Pept Sci; 2016 Jan; 22(1):28-35. PubMed ID: 26680221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
    Vu K; Gelli A
    Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy of antifungal drugs against Paracoccidioides brasiliensis and Paracoccidioides lutzii in a Galleria mellonella model.
    de Lacorte Singulani J; Scorzoni L; de Paula E Silva AC; Fusco-Almeida AM; Mendes-Giannini MJ
    Int J Antimicrob Agents; 2016 Sep; 48(3):292-7. PubMed ID: 27444116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections.
    Wambaugh MA; Denham ST; Ayala M; Brammer B; Stonhill MA; Brown JC
    Elife; 2020 May; 9():. PubMed ID: 32367801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of mastoparan analog peptides against
    Galeane MC; Gomes PC; L Singulani J; de Souza BM; Palma MS; Mendes-Giannini MJ; Almeida AM
    Future Microbiol; 2019 Sep; 14():1087-1097. PubMed ID: 31512522
    [No Abstract]   [Full Text] [Related]  

  • 16. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
    Spadari CC; Vila T; Rozental S; Ishida K
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifungal activity of selective serotonin reuptake inhibitors against Cryptococcus spp. and their possible mechanism of action.
    da Silva CR; do Amaral Valente Sá LG; Ferreira TL; Leitão AC; de Farias Cabral VP; Rodrigues DS; Barbosa AD; Moreira LEA; Filho HLP; de Andrade Neto JB; Rios MEF; Cavalcanti BC; Magalhães HIF; de Moraes MO; Vitoriano Nobre H
    J Mycol Med; 2023 Nov; 33(4):101431. PubMed ID: 37666030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An active domain SA-2 derived from cystatin-SA, and its antifungal activity.
    Liu X; Huang X; Wang J; Zhang M; Liu M; Zhou C; Ma L
    Amino Acids; 2023 Jan; 55(1):101-112. PubMed ID: 36333524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
    Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.